THAR
Income statement / Annual
Last year (2023), Tharimmune, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Tharimmune, Inc.'s net income was -$9.32 M.
See Tharimmune, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$3.56 M
|
$2.28 M
|
$1.84 M
|
$847,272.00
|
$368,732.00
|
General & Administrative
Expenses |
$5.90 M
|
$4.60 M
|
$1.37 M
|
$671,879.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$5.90 M
|
$4.60 M
|
$1.37 M
|
$671,879.00
|
$625,807.00
|
Other Expenses |
$0.00 |
$0.00 |
$1.83 M |
-$362,486.00 |
$0.00 |
Operating Expenses |
$9.46 M |
$6.88 M |
$3.21 M |
$1.52 M |
$994,539.00 |
Cost And Expenses |
$9.46 M |
$6.88 M |
$3.21 M |
$1.52 M |
$994,539.00 |
Interest Income |
$152,631.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$16,505.00 |
$1.59 M |
$831,277.00 |
$246,534.00 |
$75,074.00 |
Depreciation &
Amortization |
$167,895.00
|
$228,485.00
|
$236,558.00
|
$206,297.00
|
$171,860.00
|
EBITDA |
-$9.30 M
|
-$6.88 M
|
-$1.38 M
|
-$1.88 M
|
-$1.45 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$136,126.00
|
-$1.59 M
|
$1.00 M
|
-$609,020.00
|
-$530,935.00
|
Income Before Tax |
-$9.32 M |
-$8.47 M |
-$2.21 M |
-$2.42 M |
-$1.53 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00 |
-$228,485.00 |
$831,277.00 |
-$42,666.00 |
-$171,860.00 |
Net Income |
-$9.32 M |
-$8.47 M |
-$2.21 M |
-$2.42 M |
-$1.53 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
EPS |
-107.08 |
-280.77 |
-72.81 |
-88.05 |
-55.56 |
EPS Diluted |
-107.08 |
-280.77 |
-72.81 |
-88.05 |
-55.56 |
Weighted Average Shares
Out |
$87,029.00
|
$30,178.00
|
$30,305.00
|
$27,454.00
|
$27,454.00
|
Weighted Average Shares
Out Diluted |
$87,029.00
|
$30,178.00
|
$30,305.00
|
$27,454.00
|
$27,454.00
|
Link |
|
|
|
|
|